+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Non-Animal Alternatives Testing Market Global Report 2020-30

  • ID: 5014055
  • Report
  • April 2020
  • Region: Global
  • 200 pages
  • The Business Research Company
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • BiomimX SRL
  • Cyprotex
  • Emulate Inc.
  • HµRel Corporation
  • Promega Corporation
  • MORE
Non-Animal Alternatives Testing Market Global Report 2020-30 from the author provides the strategists, marketers and senior management with the critical information they need to assess the global non-animal alternatives testing market.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3 working days of order.
Description:

Where is the largest and fastest growing market for the non-animal alternatives testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Non-Animal Alternatives Testing market global report from the author answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider non-animal alternatives testing market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The non-animal alternatives testing market section of the report gives context. It compares the non-animal alternatives testing market with other segments of the non-animal alternatives testing market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, non-animal alternatives testing indicators comparison.
Scope

Markets Covered: 1) By Technology: Cell Culture Technology; High Throughput Technology; Molecular Imaging; Omics Technology; 2) By Method: Cellular Assay; Biochemical Assay; In Silico; Ex-vivo; 3) By End-User: Pharmaceutical Industry; Cosmetics & Household Products; Diagnostics; Chemicals Industry; Food Industry

Companies Mentioned: HµRel Corporation; Cyprotex; VITROCELL; SIMULAB; Bio-Rad Laboratories

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA and Australia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • BiomimX SRL
  • Cyprotex
  • Emulate Inc.
  • HµRel Corporation
  • Promega Corporation
  • MORE
1. Executive Summary

2. Non-Animal Alternatives Testing Market Characteristics

3. Non-Animal Alternatives Testing Market Size And Growth
3.1. Global Non-Animal Alternatives Testing Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Non-Animal Alternatives Testing Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Non-Animal Alternatives Testing Market Segmentation
4.1. Global Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Cell Culture Technology
  • High Throughput Technology
  • Molecular Imaging
  • Omics Technology
4.2. Global Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Cellular Assay
  • Biochemical Assay
  • In Silico
  • Ex-vivo
4.3. Global Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Pharmaceutical Industry
  • Cosmetics & Household Products
  • Diagnostics
  • Chemicals Industry
  • Food Industry
5. Non-Animal Alternatives Testing Market Regional And Country Analysis
5.1. Global Non-Animal Alternatives Testing Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Non-Animal Alternatives Testing Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Non-Animal Alternatives Testing Market
6.1. Asia-Pacific Non-Animal Alternatives Testing Market Overview
6.2. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Non-Animal Alternatives Testing Market
7.1. China Non-Animal Alternatives Testing Market Overview
7.2. China Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.3. China Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Non-Animal Alternatives Testing Market
8.1. India Non-Animal Alternatives Testing Market Overview
8.2. India Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Non-Animal Alternatives Testing Market
9.1. Japan Non-Animal Alternatives Testing Market Overview
9.2. Japan Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Non-Animal Alternatives Testing Market
10.1. Australia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Non-Animal Alternatives Testing Market
11.1. Indonesia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Non-Animal Alternatives Testing Market
12.1. South Korea Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Non-Animal Alternatives Testing Market
13.1. Western Europe Non-Animal Alternatives Testing Market Overview
13.2. Western Europe Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Non-Animal Alternatives Testing Market
14.1. UK Non-Animal Alternatives Testing Market Overview
14.2. UK Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Non-Animal Alternatives Testing Market
15.1. Germany Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Non-Animal Alternatives Testing Market
16.4. France Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.5. France Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Non-Animal Alternatives Testing Market
17.1. Eastern Europe Non-Animal Alternatives Testing Market Overview
17.2. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Non-Animal Alternatives Testing Market
18.1. Russia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Non-Animal Alternatives Testing Market
19.1. North America Non-Animal Alternatives Testing Market Overview
19.2. North America Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Non-Animal Alternatives Testing Market
20.1. USA Non-Animal Alternatives Testing Market Overview
20.2. USA Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Non-Animal Alternatives Testing Market
21.1. South America Non-Animal Alternatives Testing Market Overview
21.2. South America Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Non-Animal Alternatives Testing Market
22.1. Brazil Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Non-Animal Alternatives Testing Market
23.1. Middle East Non-Animal Alternatives Testing Market Overview
23.2. Middle East Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Non-Animal Alternatives Testing Market
24.1. Africa Non-Animal Alternatives Testing Market Overview
24.2. Africa Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Non-Animal Alternatives Testing Market Competitive Landscape And Company Profiles
25.1. Non-Animal Alternatives Testing Market Competitive Landscape
25.2. Non-Animal Alternatives Testing Market Company Profiles
25.2.1. HµRel Corporation
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Cyprotex
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. VITROCELL
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. SIMULAB
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Bio-Rad Laboratories
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Non-Animal Alternatives Testing Market

27. Non-Animal Alternatives Testing Market Trends And Strategies

28. Non-Animal Alternatives Testing Market Future Outlook and Potential Analysis

29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. About the Publisher
29.5. Copyright And Disclaimer
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • BiomimX SRL
  • Cyprotex
  • Emulate Inc.
  • HµRel Corporation
  • Promega Corporation
  • MORE
The non-animal alternatives testing market consists of sales of non-animal alternatives testing products and services that do not involve the use of animals for tests to determine the safety standards for products. The non-animal alternatives testing market involves testing for drugs, cosmetic products using non- animal testing methods. Organs-on-chip, In-vitro test, In-silico test are some examples of techniques and methodologies used as an alternative to animal testing.

The global non-animal alternatives testing market was worth $1.11 billion in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 11.62% and reach $1.65 billion by 2023.

The alternative to animal testing market covered in this report is segmented by technology into cell culture technology; high throughput technology; molecular imaging; omics technology. It is also segmented by method into cellular assay; biochemical assay; in silico; ex-vivo and by end-user into pharmaceutical industry; cosmetics & household products; diagnostics; chemicals industry; food industry.

The support from the government and non-governmental organisations boosts the growth of the non-animal testing market. The government organisations enforces laws and regulations, raises funds to support the non-animal testing methods such as tests on human volunteers, advanced computer-modelling techniques and also funds studies with human volunteer. In order to support the non-animal testing, US Environmental Protection Agency (EPA), in 2019, awarded $4.25 million to the USA based universities including Johns Hopkins University, Vanderbilt University, Oregon State University, and the University of California to research for alternative tests replacing animals with non-animal alternatives and to make the test procedures less painful to the laboratory animals. Similar research programs to promote non-animal testing procedures are also initiated by countries such as Denmark, Brazil, Germany, Switzerland, Australia, China and Korea. The constant support from the government drives the growth of the non-animal testing market.

Compulsory animal testing is required for the approval of sale of various products such as the pesticides, industrial chemicals, drugs, medical devices, vaccines, genetically modified foods, and some consumer products. Animal testing is still a mandatory practice in some countries due to their legal system where any special use products, non- routine tests, imported cosmetic requires animal testing. For instance, according to the UK's annual statistics of scientific procedures on living animals, in 2018, a total of 3.52 million experiments were completed on animals. According to Cruelty Free International, in 2018, in the UK almost 40 eye irritation tests, 10,275 acute lethal toxicity tests, and 638 pyrogenicity experiments were conducted on live rabbits. Cruelty Free International is an U.K based animal protection and advocacy group. The legal requirements in some countries for compulsory animal testing will hamper the growth of the market.

The companies in the non-animal testing market are increasingly investing in technologies such as organs on the chip technology as an alternative to animal testing. Organs- on the- chip method contains human cells on a chip which mimics the structure and function of human organs and organs system instead of using of animal for the test. Following the trend, in 2018, Emulate was funded an amount of $36 million from its founder's fund and ALS Investment Fund, SciFi VC, GlassWall Syndicate Association to extended its biological capabilities to Liver-Chip, Intestine-Chip, Lung-Chip, and Brain-Chip, and to its human-relevant models of thrombosis and immune system modulation. ALS Investment Fund, SciFi VC and GlassWall Syndicate Association are venture capital and private equity firm that supports and finances biotech companies.

In 2018, Thermo Fisher Scientific Inc., a USA based life sciences research company, acquired Advanced Bioprocessing business from Becton, Dickinson and Company for $477 million in cash. Through this acquistion Thermo Fisher Scientific Inc. aimed to expand its bioproduction portfolio by utilising the cell-culture media products of the Becton, Dickinson and Company. The Becton, Dickinson and Company is a USA based medical device company.

Major players in the market are HµRel Corporation, Cyprotex, VITROCELL, SIMULAB, Bio-Rad Laboratories, GE Healthcare, SGS SA, BioIVT, Abbott Laboratoriesand Gentronix Limited.
Note: Product cover images may vary from those shown
4 of 5
  • HµRel Corporation
  • Cyprotex
  • VITROCELL
  • SIMULAB
  • Bio-Rad Laboratories
  • GE Healthcare
  • SGS SA
  • BioIVT
  • Abbott Laboratories
  • Gentronix Limited
  • Promega Corporation
  • MB Research Laboratories
  • Qiagen N.V.
  • Urban Decay
  • Catalent, Inc.
  • Evotec AG (Cyprotex plc)
  • Ecotec AG (Cyprotex plc)
  • Catalent, Inc
  • Thermo Fisher Scientific
  • Laboratory Corporation of America Holdings
  • Charles River Laboratories, Inc.
  • Agilent Technologies, Inc.
  • BioReliance Corporation (a subsidiary of Merck KGaA)
  • Ecco Bella
  • Bare Blossom
  • Billy Jealousy
  • MuLondon Organic
  • Modern Minerals Makeup
  • BiomimX SRL
  • Elveflow
  • Emulate Inc.
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll